Question 1

What merger control clearances does the deal in the United States require before completion?

Accepted Answer

The deal requires merger control clearance in the United States as a condition to completion.

Question 2

When is the mid-term synergy realisation milestone expected to be reached?

Accepted Answer

Management expects more than half of the $55m synergies to be realised by December 31, 2028.

Question 3

How much did AMS net debt increase to on 16 September 2026?

Accepted Answer

On 16 September 2026, AMS net debt increased to £60.3m from £50.5m at the prior year-end.

Question 4

How did Advanced Medical Solutions (AMS) describe the drivers of its pre-tax profit in its H1 results?

Accepted Answer

AMS reported pre-tax profit of £0.3m and said it was driven by £12.4m exceptional costs related to its operational synergy programme and the proposed H.B. Fuller acquisition.

Question 5

What site closures did Advanced Medical Solutions (AMS) plan by end-March 2027?

Accepted Answer

AMS planned closures of five sites in Germany and Czechia by end-March 2027.

Question 6

When did AMS shareholders approve H.B. Fuller’s cash acquisition of AMS?

Accepted Answer

AMS shareholders approved H.B. Fuller’s cash acquisition of AMS on 16 September 2026. The scheme of arrangement was expected to become effective in the fourth quarter, after competition clearances from German, UK and Austrian authorities.

Timeline

H.B. Fuller

Advanced Medical Solutions lifts revenue as H.B. Fuller takeover nears completion

H.B. Fuller to acquire Advanced Medical Solutions for £695m

More in Healthcare

IP Group leads £4m funding round for AI materials spin-out

hVIVO appoints Angela Hildreth as Chief Financial Officer

Genflow wins Japanese patent allowance for SIRT6 therapy

Scancell widens annual loss

Verici Dx opens retail offer after £8.5m placing

Sareum signals intention to launch equity capital raise

MedPal AI confirms no equity raise planned as it seeks working capital facility

Futura Medical continues sale process, finance director steps down

Bunzl acquires UK care home products distributor Blueleaf Care

Futura Medical reports stronger user results for optimised Eroxon Intense

Health & Bio Today: Avacta, Cambridge Cognition, MedPal AI, Smith+Nephew, Poolbeg Pharma, OKYO Pharma

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer